US RNA FOR CANCER THERAPY
patentscope.wipo.int
This patent search tool allows you not only to search the PCT database of about 2 million International Applications but also the worldwide patent collections....
31st Annual Meeting and Associated Programs of the Society ...www.scienceopen.com › document
www.scienceopen.com
... Stosnach , Birgit Scheel , Andreas Schroeder , Tobias Seibel , Ulrike Gnad-Vogt ... Roche Diagnostics GmbH, Penzberg, Germany; 3Technion Institute, Haifa, ... Tobias Seibel15, Ulrike Gnad-Vogt15, Alfred Zippelius14 1CureVac AG, ... Dream Team Translational Research Grant, Breast Cancer Research ...
Self-adjuvanted mRNA vaccination in advanced prostate cancer...
www.urotoday.com
Prostate Cancer Immunotherapy
Phase Ib study evaluating a self-adjuvanted mRNA cancer ...www.scienceopen.com › document
www.scienceopen.com
Karl-Josef Kallen: . Ulrike Gnad-Vogt: . Alfred Zippelius: Alfred.Zippelius@usb.
Society for Immunotherapy of Cancer - The SITC Immune ...sitc.sitcancer.org › UserFiles › file › JournalforImmunoTherapyofCance...
sitc.sitcancer.org
If you or someone you know is interested in joining the JITC team, please visit ... Ulrike Gnad-Vogt, Kurt Miller, Wolfgang Schultze-Seemann, Frank vom Dorp, ...
Journal for immunotherapy of cancer reviewer acknowledgement |...
jitc.biomedcentral.com
On behalf of the JITC Section Editors and Associate Editors, I wish to acknowledge with sincere appreciation the assistance of the following reviewers who...
OPUS 4 | Phase Ib study evaluating a self-adjuvanted mRNA cancer...
publikationen.ub.uni-frankfurt.de
... Gerd Rippin, Sven D. Koch, Birgit Scheel, Mariola Fotin-Mleczek, Regina Heidenreich, Karl-Josef Kallen, Ulrike Gnad-Vogt, Alfred Zippelius.
October – Page 18 – 1stOncology™: Cancer Intelligence Service
www.1stoncology.com
Ulrike Gnad-Vogt, M.D., CMO of CureVac, commented, “The initiation of Value to the Team While Furthering Your Own Career Development
Alle Infos zum Namen "Ulrike Gnad-Vogt"
Debra Barker's Post
www.linkedin.com
Ulrike Gnad-Vogt, our SVP Area Head Oncology, sat down with The Medicine Maker to discuss the versatility of #mRNA – including its application in #cancer ... Ulrike Gnad-Vogt, our SVP Area Head Oncology, sat down with The Medicine Maker to discuss the versatility of #mRNA – including its application in #cancer ...
Self-adjuvanted mRNA vaccination in advanced prostate cancer...
www.infona.pl
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study. Hubert Kübler, Birgit Scheel, Ulrike Gnad-Vogt, Kurt ...
Inventors list Gm-Go - Patent application
www.patentsencyclopedia.com
Ulrike Gnad-Vogt, DE, Frankfurt, Cancer Treatments with Radiation and Immunocytokines, 1. Matthew R. Gnagy, US, Incline ...
More articles from Novel Strategies for Cancer Vaccines | The Journal...
www.jimmunol.org
... Dähling, Tilmann Roos, Aleksandra Kowalczyk, Patrick Baumhof, Birgit Scheel, Söhnke Voss, Karl-Josef Kallen, Mariola Fotin-Mleczek and Ulrike Gnad-Vogt.
A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in...
fis-uke.de
... Strack; Volker Wiegand; Ulrike Gnad-Vogt; Karl-Josef Kallen; Ingmar Hoerr; Florian von der Muelbe; Mariola Fotin-Mleczek; Alexander Knuth; Sven D Koch ...
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine...
read.qxmd.com
... Gerd Rippin, Sven D Koch, Birgit Scheel, Mariola Fotin-Mleczek, Regina Heidenreich, Karl-Josef Kallen, Ulrike Gnad-Vogt, Alfred Zippelius.
Ulrike - Patent applications
www.patentsencyclopedia.com
Ulrike Gnad-Vogt, Frankfurt DE. Patent application number, Description, Published , Cancer Treatments with Radiation and Immunocytokines ...
Verwandte Suchanfragen zu Ulrike Gnad-Vogt
| Claudia Stosnach Andreas Schroeder Tobias Seibel | Alfred Zippelius Ingmar Hoerr Birgit Scheel | Kurt Miller Karl-Josef Kallen Sven Koch |
Personen Vorname "Ulrike" (34734) Name "Gnad-Vogt" (5) |
sortiert nach Relevanz / Datum